Arkansas became the third state to create work requirements for Medicaid since the Trump administration announced it would allow them.
Arkansas became third state to create work requirements for those receiving health benefits under Medicaid expansion, after CMS approved the state’s plan, which features the strictest lockout seen so far.
The Arkansas Works program requires those eligible between the ages of 19 and 49 to demonstrate they have worked or engaged in job searches, training, school, health education, or volunteering for 80 hours per month to keep Medicaid benefits. Those who fail to do so for 3 months in a calendar year lose coverage for the rest of the calendar year, according to a statement from Governor Asa Hutchinson’s office.
Exempt persons include the medically frail and disabled, pregnant women, those in substance abuse treatment, those caring for a sick person or minor child, and anyone already except from work requirements for the Supplemental Nutrition Assistance Program.
“I have often said that Arkansans understand the dignity of work,” Hutchinson said. “The approval of this work requirement will go a long way to create opportunities for able-bodied working-age Arkansans to enter into training or employment and ultimately climb the economic ladder.”
CMS Administrator Seema Verma was on hand to deliver Arkansas’ approval document. Prior to joining the Trump administration, she was a consultant who developed the work requirements that were recently approved for the Kentucky and Indiana Medicaid programs (Verma recused herself on those approvals).
In the statement, Hutchinson’s office said that a voluntary work referral program implemented last year had already shown success. Those who used the referral program were more likely to find a job than those who did not use the service. With mandatory work requirements, Arkansas officials expect more beneficiaries to take advantage of the referral service, the statement said.
Work requirements will be phased in over 4 months between June and September this year, starting with those 30 to 49 years old.
So far, CMS has not acted on Arkansas’ request to cap Medicaid at 100% of the poverty level without taking away any of the extra funds it had been receiving under the Affordable Care Act. Local reports in Arkansas estimate this would save the state $356 million a year while ending coverage for 61,000 people.
The work rules are expected to affect 39,000 people, although it is not known how much the rolls will shrink. Arkansas has about 285,000 people in Medicaid.
Kentucky has already been sued over its work rule requirements.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More